NEP INTERLONG (08329) expects a year-on-year decrease of approximately 240% to 280% in its shareholders' net profit for the year 2025.
Kingwood International (08329) issues a supplementary announcement regarding profit warning. Based on further evaluation of the unaudited comprehensive management accounts for the year 2025 (the "2025 Year") of the Group and other information currently available, it is expected that the Group's attributable net profit for the 2025 Year will decrease by approximately 240% to 280% compared to the same period in 2024. The main reason for the decrease is the impairment loss on goodwill formed during the acquisition of Beijing Kingwood Biopharmaceutical Co., Ltd.
NEP Interlong (08329) has released a supplementary announcement regarding the profit warning. Based on the further evaluation of the unaudited comprehensive management accounts of the Group for the year 2025 and other available information at present, it is expected that the Group's attributable profit to the equity shareholders of the Company for the year 2025 will decrease by approximately 240% to 280% compared to the same period in 2024, with the main reason for the decrease being the impairment loss on goodwill formed during the acquisition of Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
Related Articles
TYSAN HOLDINGS (00687) released its annual performance, with a net profit attributable to shareholders of HK$61.317 million, an increase of 50.31% year-on-year.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-3836 Injection Obtains Drug Clinical Trial Approval Notification
Shenzhen Kangtai Biological Products (300601.SZ): Four-strain influenza virus split vaccines obtained drug registration certificate.
TYSAN HOLDINGS (00687) released its annual performance, with a net profit attributable to shareholders of HK$61.317 million, an increase of 50.31% year-on-year.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-3836 Injection Obtains Drug Clinical Trial Approval Notification
Shenzhen Kangtai Biological Products (300601.SZ): Four-strain influenza virus split vaccines obtained drug registration certificate.
RECOMMEND
State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026
Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026
Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026
